{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:38:03Z","timestamp":1790746683096,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1093\/carcin\/bgh083","type":"journal-article","created":{"date-parts":[[2004,3,4]],"date-time":"2004-03-04T21:24:47Z","timestamp":1078435487000},"page":"901-908","source":"Crossref","is-referenced-by-count":48,"title":["Activation of \u03b2-catenin provides proliferative and invasive advantages in c-myc \/TGF-\u03b1 hepatocarcinogenesis promoted by phenobarbital"],"prefix":"10.1093","volume":"25","author":[{"given":"Diego F.","family":"Calvisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ladu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina M.","family":"Factor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snorri S.","family":"Thorgeirsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,6]]},"reference":[{"key":"key\n\t\t\t\t20170521002856_B1","unstructured":"Jirtle,R.L., Meyer,S.A. and Brockenbrough,J.S. ( 1991 ) Liver tumor promoter phenobarbital: a biphasic modulator of hepatocyte proliferation. Prog. Clin. Biol. Res. , 369 , 209 \u2013216."},{"key":"key\n\t\t\t\t20170521002856_B2","unstructured":"Brockenbrough,J.S., Meyer,S.A., Li,C.X. and Jirtle,R.L. ( 1991 ) Reversible and phorbol ester-specific defect of protein kinase C translocation in hepatocytes isolated from phenobarbital-treated rats. Cancer Res. , 51 , 130 \u2013136."},{"key":"key\n\t\t\t\t20170521002856_B3","doi-asserted-by":"crossref","unstructured":"Bursch,W., Lauer,B., Timmermann-Trosiener,I., Barthel,G., Schuppler,J. and Schulte-Hermann,R. ( 1984 ) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis , 5 , 453 \u2013458.","DOI":"10.1093\/carcin\/5.4.453"},{"key":"key\n\t\t\t\t20170521002856_B4","doi-asserted-by":"crossref","unstructured":"Guppy,M.J., Wilton,J.C., Sharma,R., Coleman,R. and Chipman,J.K. ( 1994 ) Modulation of phenobarbitone-induced loss of gap junctional intercellular communication in hepatocyte couplets. Carcinogenesis , 15 , 1917 \u20131921.","DOI":"10.1093\/carcin\/15.9.1917"},{"key":"key\n\t\t\t\t20170521002856_B5","unstructured":"Murakami,H., Sanderson,N.D., Nagy,P., Marino,P.A., Merlino,G. and Thorgeirsson,S.S. ( 1993 ) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res. , 53 , 1719 \u20131723."},{"key":"key\n\t\t\t\t20170521002856_B6","unstructured":"Santoni-Rugiu,E., Nagy,P., Jensen,M.R., Factor,V.M. and Thorgeirsson,S.S. ( 1996 ) Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Am. J. Pathol. , 149 , 407 \u2013428."},{"key":"key\n\t\t\t\t20170521002856_B7","unstructured":"Santoni-Rugiu,E., Jensen,M.R. and Thorgeirsson,S.S. ( 1998 ) Disruption of the pRb\/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor \u03b1. Cancer Res. , 58 , 123 \u2013134."},{"key":"key\n\t\t\t\t20170521002856_B8","doi-asserted-by":"crossref","unstructured":"Sanders,S. and Thorgeirsson,S.S. ( 1999 ) Phenobarbital promotes liver growth in c-myc\/TGF-alpha transgenic mice by inducing hypertrophy and inhibiting apoptosis. Carcinogenesis , 20 , 41 \u201349.","DOI":"10.1093\/carcin\/20.1.41"},{"key":"key\n\t\t\t\t20170521002856_B9","doi-asserted-by":"crossref","unstructured":"Sanders,S. and Thorgeirsson,S.S. ( 2002 ) Promotion of hepatocarcinogenesis by phenobarbital in c-myc\/TGF-alpha transgenic mice. Mol. Carcinogen. , 28 , 168 \u2013173.","DOI":"10.1002\/1098-2744(200007)28:3<168::AID-MC5>3.0.CO;2-E"},{"key":"key\n\t\t\t\t20170521002856_B10","doi-asserted-by":"crossref","unstructured":"Aydinlik,H., Nguyen,T.D., Moennikes,O., Buchmann,A. and Schwarz,M. ( 2001 ) Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors. Oncogene , 20 , 7812 \u20137816.","DOI":"10.1038\/sj.onc.1204982"},{"key":"key\n\t\t\t\t20170521002856_B11","doi-asserted-by":"crossref","unstructured":"Ozawa,M. and Kemler,R. ( 1992 ) Molecular organization of the uvomorulin-catenin complex. J. Cell. Biol. , 116 , 989 \u2013996.","DOI":"10.1083\/jcb.116.4.989"},{"key":"key\n\t\t\t\t20170521002856_B12","doi-asserted-by":"crossref","unstructured":"Chen,H., Paradies,N.E., Fedor-Chaiken,M. and Brackenbury,R. ( 1997 ) E-cadherin mediates adhesion and suppresses cell motility via distinct mechanisms. J. Cell. Sci. , 110 , 345 \u2013356.","DOI":"10.1242\/jcs.110.3.345"},{"key":"key\n\t\t\t\t20170521002856_B13","doi-asserted-by":"crossref","unstructured":"Polakis,P. ( 2000 ) Wnt signaling and cancer. Genes Dev. , 14 , 1837 \u20131851.","DOI":"10.1101\/gad.14.15.1837"},{"key":"key\n\t\t\t\t20170521002856_B14","doi-asserted-by":"crossref","unstructured":"Kikuchi,A. ( 2000 ) Regulation of \u03b2-catenin signaling in the Wnt Pathway. Biochem. Biophys. Res. Commun. , 268 , 243 \u2013248.","DOI":"10.1006\/bbrc.1999.1860"},{"key":"key\n\t\t\t\t20170521002856_B15","doi-asserted-by":"crossref","unstructured":"Crawford,H.C., Fingleton,B.M., Rudolph-Owen,L.A., Goss,K.J., Rubinfeld,B., Polakis,P. and Matrisian,L.M. ( 1999 ) The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene , 18 , 2883 \u20132891.","DOI":"10.1038\/sj.onc.1202627"},{"key":"key\n\t\t\t\t20170521002856_B16","unstructured":"Calvisi,D.F., Factor,V.M., Loi,R. and Thorgeirsson,S.S. ( 2001 ) Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Cancer Res. , 61 , 2085 \u20132091."},{"key":"key\n\t\t\t\t20170521002856_B17","unstructured":"Frith,C.H., Ward,J.M. and Turusov,V.S. ( 1995 ) Tumours of the liver. In Turusov,V. and Mohr,U. (eds) Pathology of Tumours in Laboratory Animals . IARC, IARC Scientific Publications, Lyon, vol. 2, pp. 223\u2013270."},{"key":"key\n\t\t\t\t20170521002856_B18","doi-asserted-by":"crossref","unstructured":"De La Coste,A., Romagnolo,B., Billuart,P. et al . ( 1998 ) Somatic mutations of the \u03b2-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA , 95 , 8847 \u20138851.","DOI":"10.1073\/pnas.95.15.8847"},{"key":"key\n\t\t\t\t20170521002856_B19","doi-asserted-by":"crossref","unstructured":"Engelhardt,N.V., Factor,V.M., Yasova,A.K., Poltoranina,V.S., Baranov,V.N. and Lasareva,M.N. ( 1990 ) Common antigens of mouse oval and biliary epithelial cells. Expression on newly formed hepatocytes. Differentiation , 45 , 29 \u201337.","DOI":"10.1111\/j.1432-0436.1990.tb00453.x"},{"key":"key\n\t\t\t\t20170521002856_B20","doi-asserted-by":"crossref","unstructured":"Yan,D., Wiesmann,M., Rohan,M. et al . ( 2001 ) Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt\/beta -catenin signaling is activated in human colon tumors. Proc. Natl Acad. Sci. USA , 98 , 14973 \u201314978.","DOI":"10.1073\/pnas.261574498"},{"key":"key\n\t\t\t\t20170521002856_B21","doi-asserted-by":"crossref","unstructured":"Lustig,B., Jerchow,B., Sachs,M. et al . ( 2002 ) Negative feedback loop of Wnt signaling through upregulation of conductin\/axin2 in colorectal and liver tumors. Mol. Cell. Biol. , 22 , 1184 \u20131193.","DOI":"10.1128\/MCB.22.4.1184-1193.2002"},{"key":"key\n\t\t\t\t20170521002856_B22","doi-asserted-by":"crossref","unstructured":"Leung,J.Y., Kolligs,F.T., Wu,R., Zhai,Y., Kuick,R., Hanash,S., Cho,K.R. and Fearon,E.R. ( 2002 ) Activation of AXIN2 expression by beta-catenin\/T cell factor. A feedback repressor pathway regulating Wnt signaling. J. Biol. Chem. , 277 , 21657 \u201321665.","DOI":"10.1074\/jbc.M200139200"},{"key":"key\n\t\t\t\t20170521002856_B23","doi-asserted-by":"crossref","unstructured":"Behrens,J. ( 1999 ) Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev. , 18 , 15 \u201330.","DOI":"10.1023\/A:1006200102166"},{"key":"key\n\t\t\t\t20170521002856_B24","doi-asserted-by":"crossref","unstructured":"Nawrocki,B., Polette,M., Van Hengel,J., Tournier,J.M., Van Roy,F. and Birembault,P. ( 1998 ) Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am. J. Pathol. , 153 , 1521 \u20131530.","DOI":"10.1016\/S0002-9440(10)65740-9"},{"key":"key\n\t\t\t\t20170521002856_B25","unstructured":"Davies,G., Jiang,W.G. and Mason,M.D. ( 2001 ) Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor\/scatter factor-induced cell-cell dissociation and in vitro invasion. Clin. Cancer Res. , 7 , 3289 \u20133297."},{"key":"key\n\t\t\t\t20170521002856_B26","doi-asserted-by":"crossref","unstructured":"Li,Y., Bharti,A., Chen,D., Gong,J. and Kufe,D. ( 1998 ) Interaction of glycogen synthase kinase 3beta with the DF3\/MUC1 carcinoma-associated antigen and beta-catenin. Mol. Cell. Biol. , 18 , 7216 \u20137224.","DOI":"10.1128\/MCB.18.12.7216"},{"key":"key\n\t\t\t\t20170521002856_B27","doi-asserted-by":"crossref","unstructured":"Miller,J.R., Hocking,A.M., Brown,J.D. and Moon,R.T. ( 1999 ) Mechanism and function of signal transduction by the Wnt\/beta-catenin and Wnt\/Ca2+ pathways. Oncogene , 18 , 7860 \u20137872.","DOI":"10.1038\/sj.onc.1203245"},{"key":"key\n\t\t\t\t20170521002856_B28","doi-asserted-by":"crossref","unstructured":"Giles,R.H., van Es,J.H. and Clevers,H. ( 2003 ) Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta , 1653 , 1 \u201324.","DOI":"10.1016\/S0304-419X(03)00005-2"},{"key":"key\n\t\t\t\t20170521002856_B29","doi-asserted-by":"crossref","unstructured":"Ougolkov,A.V., Yamashita,K., Mai,M. and Minamoto,T. ( 2002 ) Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer. Gastroenterology , 122 , 60 \u201371.","DOI":"10.1053\/gast.2002.30306"},{"key":"key\n\t\t\t\t20170521002856_B30","doi-asserted-by":"crossref","unstructured":"Schroeder,J.A., Adriance,M.C., Thompson,M.C., Camenisch,T.D. and Gendler,S.J. ( 2003 ) MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene , 22 , 1324 \u20131332.","DOI":"10.1038\/sj.onc.1206291"},{"key":"key\n\t\t\t\t20170521002856_B31","doi-asserted-by":"crossref","unstructured":"Takahashi,M., Tsunoda,T., Seiki,M., Nakamura,Y. and Furukawa,Y. ( 2002 ) Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin\/Tcf4 complex in human colorectal cancers. Oncogene , 21 , 5861 \u20135867.","DOI":"10.1038\/sj.onc.1205755"},{"key":"key\n\t\t\t\t20170521002856_B32","doi-asserted-by":"crossref","unstructured":"Marchenko,G.N., Marchenko,N.D., Leng,J. and Strongin,A.Y. ( 2002 ) Promoter characterization of the novel human matrix metalloproteinase-26 gene: regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin. Biochem. J. , 363 , 253 \u2013262.","DOI":"10.1042\/bj3630253"},{"key":"key\n\t\t\t\t20170521002856_B33","unstructured":"Irby,R.B. and Yeatman,TJ. ( 2002 ) Src activity disrupts cadherin\/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res. , 62 , 2669 \u20132674."},{"key":"key\n\t\t\t\t20170521002856_B34","unstructured":"Hiscox,S. and Jiang,W.G. ( 1999 ) Hepatocyte growth factor\/scatter factor disrupts epithelial tumour cell-cell adhesion: involvement of beta-catenin. Anticancer Res. , 19 , 509 \u2013517."},{"key":"key\n\t\t\t\t20170521002856_B35","unstructured":"Cadoret,A., Ovejero,C., Saadi-Kheddouci,S., Souil,E., Fabre,M., Romagnolo,B., Kahn,A. and Perret,C. ( 2001 ) Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res. , 61 , 3245 \u20133249."},{"key":"key\n\t\t\t\t20170521002856_B36","doi-asserted-by":"crossref","unstructured":"Monga,S.P., Pediaditakis,P., Mule,K., Stolz,D.B. and Michalopoulos,G.K. ( 2001 ) Changes in WNT\/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology , 33 , 1098 \u20131109.","DOI":"10.1053\/jhep.2001.23786"},{"key":"key\n\t\t\t\t20170521002856_B37","doi-asserted-by":"crossref","unstructured":"Monga,S.P., Monga,H.K., Tan,X., Mule,K., Pediaditakis,P. and Michalopoulos,G.K. ( 2003 ) Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology , 124 , 202 \u2013216.","DOI":"10.1053\/gast.2003.50000"},{"key":"key\n\t\t\t\t20170521002856_B38","doi-asserted-by":"crossref","unstructured":"Cadoret,A., Ovejero,C., Terris,B., Souil,E., Levy,L., Lamers,W.H., Kitajewski,J., Kahn,A. and Perret,C. ( 2002 ) New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene , 21 , 8293 \u20138301.","DOI":"10.1038\/sj.onc.1206118"},{"key":"key\n\t\t\t\t20170521002856_B39","unstructured":"Loeppen,S., Schneider,D., Gaunitz,F., Gebhardt,R., Kurek,R., Buchmann,A. and Schwarz,M. ( 2002 ) Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital. Cancer Res. , 62 , 5685 \u20135688."},{"key":"key\n\t\t\t\t20170521002856_B40","doi-asserted-by":"crossref","unstructured":"Factor,V.M., Oliver,A.L., Panta,G.R., Thorgeirsson,S.S., Sonenshein,G.E. and Arsura,M. ( 2001 ) Roles of Akt\/PKB and IKK complex in constitutive induction of NF-kappaB in hepatocellular carcinomas of transforming growth factor alpha\/c-myc transgenic mice. Hepatology , 34 , 32 \u201341.","DOI":"10.1053\/jhep.2001.25270"}],"container-title":["Carcinogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/carcin\/article-pdf\/25\/6\/901\/17284288\/bgh083.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T02:02:49Z","timestamp":1682647369000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/carcin\/article-lookup\/doi\/10.1093\/carcin\/bgh083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,6]]},"published-print":{"date-parts":[[2004,6]]}},"URL":"https:\/\/doi.org\/10.1093\/carcin\/bgh083","relation":{},"ISSN":["1460-2180","0143-3334"],"issn-type":[{"value":"1460-2180","type":"electronic"},{"value":"0143-3334","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}